Digital Penicillin Production

For thousands of years, micro-organisms have been used to facilitate chemical reactions - in beer brewing, for example. However, biochemical processes are incredibly complex, with a multitude of reactions taking place simultaneously and influencing one another. There are countless parameters that play a role, not all of which can be directly measured.

Despite the difficulties involved, researchers at TU Wien are now working on examining these processes in detail. Now, in cooperation with pharmaceutical manufacturer Sandoz, TU Wien has succeeded in analysing and comprehensively replicating a penicillin production process using a computer model. This process has even enabled researchers to determine parameters that cannot be measured directly. Sandoz is now making use of these findings to keep a full overview of the processes in the bioreactor at all times, ensuring optimum quality.

Black box replaced by in-depth knowledge

Many chemical reactions are easy to understand: if hydrogen is burned with oxygen, water is produced - in a clearly predictable manner and in a volume that can be precisely calculated beforehand. But how can you calculate how quickly a fungus will grow and proliferate under the constantly changing conditions in a bioreactor?

"For a long time, processes like this were seen as a 'black box' that cannot be understood and that can only be effectively exploited with a lot of experience," says Prof. Christoph Herwig, who leads the research group for bioprocess technology at TU Wien's Institute of Chemical, Environmental and Bioscience Engineering. "Our approach is somewhat different: we want to analyse the chemical processes in a bioreactor in detail and determine the equations that describe these processes." The aim is to produce a mathematical model that accurately replicates these processes within the bioreactor.

"Many parameters that are vital to the process simply cannot be directly measured, such as the growth rate of the micro-organisms," explains Julian Kager, who is working with Sandoz GmbH as part of his dissertation. "This is precisely why a comprehensive mathematical model is so useful: we use accessible data from the production process in real time, such as the concentration of various substances in the bioreactor, and use our computer model to calculate the most probable state of the process." The parameters that can't be measured can therefore be calculated.

The model information can be used to optimise the nutrient supply to the cultivated cells while the process is ongoing.

The system of equations used to mathematically describe the bioprocess is as complex and multifaceted as the process itself. "The system of equations describes a non-linear dynamic system. Even the smallest variations in the starting conditions can have a huge impact," explains Kager. "This means it's not really possible to simply work out a solution by hand; instead, relatively elaborate computer simulations are required to obtain the needed results."

The process model and algorithms developed at TU Wien are now being used by Sandoz GmbH for its penicillin production process. "We are very pleased that our basic research has been adopted for use in industry so quickly and that our approach of biochemical modelling is now being used to facilitate the automated control of pharmaceutical production processes," says Julian Kager.

Julian Kagera, Christoph Herwigab, Ines Viktoria Stelzercd.
State estimation for a penicillin fed-batch process combining particle filtering methods with online and time delayed offline measurements.
Chemical Engineering Science, Volume 177, 23 February 2018, Pages 234-244. doi: 10.1016/j.ces.2017.11.049.

Most Popular Now

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

When it comes to Emergency Care, ChatGPT…

If ChatGPT were cut loose in the Emergency Department, it might suggest unneeded x-rays and antibiotics for some patients and admit others who didn't require hospital treatment, a new study...

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...